The effect of smoking in pregnancy on maternal serum inhibin A levels

Prenatal Diagnosis

Volumn 19, Issue 4, 1999, Pages 372-374

  Ferriman, E L ^a   Sehmi, I K ^b   Jones, R ^b   Cuckle, H S ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

Inhibin; Maternal serum; Second trimester; Smoking

Indexed keywords

INHIBIN A;

ARTICLE; BLOOD LEVEL; DATA BASE; FEMALE; HUMAN; MATERNAL SERUM; NORMAL HUMAN; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SMOKING;

ADULT; FEMALE; GESTATIONAL AGE; HUMANS; INHIBINS; PREGNANCY; REFERENCE VALUES; SMOKING;

EID: 0032965370     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199904)19:4<372::AID-PD537>3.0.CO;2-O     Document Type: Article

References (17)

1. Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, Groome NP, Macri JM. 1996. Dimeric inhibin A as a marker for Down's syndrome and Trisomy 18 pregnancies at 7-18 weeks' gestation. N Engl J Med 334: 1231-1236.
2. Bartels I, Hoppe-Sievert B, Bockel B, Herold S, Caesar J. 1993. Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol to maternal weight and smoking. Prenat Diagn 13: 123-130.
3. Bernstein L, Pike MC, Lobo RA, Depue RH, Ross RK, Henderson BE. 1989. Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels. Br J Obstet Gynaecol 96: 92-96.
4. Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM. 1996. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Prenat Diagn 16: 1095-1100.
5. Cuckle HS, Sehmi IK, Jones R. 1998. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynaecol 105: 1101-1103.
6. Cuckle HS, Wald NJ, Densem JW, Royston P. 1990. The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehdro-epiandrosterone sulphate levels. Br J Obstet Gynaecol 97: 272-276.
7. Khalil A, Kaufman RC, Wortsman J, Winters SJ, Huffman DG. 1994. Inhibin in normal and abnormal pregnancy: maternal serum concentration and partial characterization. Am J Obstet Gynecol 172: 1019-1025.
8. Lambert-Messerlian GM, Canick JA, Palomaki GE, Schneyer AL. 1996. Second trimester levels of maternal serum inhibin-A, total inhibin, a inhibin precursor and activin in Down's syndrome pregnancies. J Med Screen 3: 58-62.
9. Muttukrishna S, Knight PG, Groome NP, Redman CWG, Ledger WL. 1997. Activin A and inhibin A as possible endocrine markers of pre-eclampsia. Lancet 349: 1285-1288.
10. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. 1993. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estiol, and hCG: impact on Down syndrome screening. Obstet Gynecol 81: 675-678.
11. Spencer K. 1993. Correcting for smoking in Down's syndrome screening. Clin Chem 39: A1169.
12. Spencer K. 1998. The influence of smoking on maternal serum AFP and free beta hCG levels and the impact on screening for Down's syndrome. Prenat Diagn 18: 225-234.
13. Spencer K, Wallace EM, Ritoe S. 1996. Second trimester dimeric inhibin-A in Down's syndrome screening. Prenat Diagn 16: 1101-1110.
14. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. 1996. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16: 143-153.
15. Wallace EM, Swanston IA, McNeilly AS, Ashby JP, Blundell G, Calder AA, Groome NP. 1996. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin Endocrinol 44: 17-21.
16. Wenstrom KD, Owen J, Chu DC, Boots L. 1997. α-fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three analyte, multiple marker screening test for fetal Down's syndrome. Am J Obstet Gynecol. 177: 987-991.
17. Wheeler T, Sollero C, Landen J, Anthony F, Osmond C. 1994. Relation between maternal haemoglobin and placental hormone concentrations in early pregnancy. Lancet 343: 511-513.